Jere Khuzwayo C, Chaguza Chrispin, Bar-Zeev Naor, Lowe Jenna, Peno Chikondi, Kumwenda Benjamin, Nakagomi Osamu, Tate Jacqueline E, Parashar Umesh D, Heyderman Robert S, French Neil, Cunliffe Nigel A, Iturriza-Gomara Miren
Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom
Malawi-Liverpool-Wellcome Trust Clinical Research Programme/Department of Medical Laboratory Sciences, College of Medicine, University of Malawi, Blantyre, Malawi.
J Virol. 2018 Jan 17;92(3). doi: 10.1128/JVI.01246-17. Print 2018 Feb 1.
To combat the high burden of rotavirus gastroenteritis, multiple African countries have introduced rotavirus vaccines into their childhood immunization programs. Malawi incorporated a G1P[8] rotavirus vaccine (Rotarix) into its immunization schedule in 2012. Utilizing a surveillance platform of hospitalized rotavirus gastroenteritis cases, we examined the phylodynamics of G1P[8] rotavirus strains that circulated in Malawi before (1998 to 2012) and after (2013 to 2014) vaccine introduction. Analysis of whole genomes obtained through next-generation sequencing revealed that all randomly selected prevaccine G1P[8] strains sequenced ( = 32) possessed a Wa-like genetic constellation, whereas postvaccine G1P[8] strains ( = 18) had a DS-1-like constellation. Phylodynamic analyses indicated that postvaccine G1P[8] strains emerged through reassortment events between human Wa- and DS-1-like rotaviruses that circulated in Malawi from the 1990s and hence were classified as atypical DS-1-like reassortants. The time to the most recent common ancestor for G1P[8] strains was from 1981 to 1994; their evolutionary rates ranged from 9.7 × 10 to 4.1 × 10 nucleotide substitutions/site/year. Three distinct G1P[8] lineages chronologically replaced each other between 1998 and 2014. Genetic drift was the likely driver for lineage turnover in 2005, whereas replacement in 2013 was due to reassortment. Amino acid substitution within the outer glycoprotein VP7 of G1P[8] strains had no impact on the structural conformation of the antigenic regions, suggesting that it is unlikely that they would affect recognition by vaccine-induced neutralizing antibodies. While the emergence of DS-1-like G1P[8] rotavirus reassortants in Malawi was therefore likely due to natural genotype variation, vaccine effectiveness against such strains needs careful evaluation. The error-prone RNA-dependent RNA polymerase and the segmented RNA genome predispose rotaviruses to genetic mutation and genome reassortment, respectively. These evolutionary mechanisms generate novel strains and have the potential to lead to the emergence of vaccine escape mutants. While multiple African countries have introduced a rotavirus vaccine, there are few data describing the evolution of rotaviruses that circulated before and after vaccine introduction. We report the emergence of atypical DS-1-like G1P[8] strains during the postvaccine era in Malawi. Three distinct G1P[8] lineages circulated chronologically from 1998 to 2014; mutation and reassortment drove lineage turnover in 2005 and 2013, respectively. Amino acid substitutions within the outer capsid VP7 glycoprotein did not affect the structural conformation of mapped antigenic sites, suggesting a limited effect on the recognition of G1-specific vaccine-derived antibodies. The genes that constitute the remaining genetic backbone may play important roles in immune evasion, and vaccine effectiveness against such atypical strains needs careful evaluation.
为应对轮状病毒肠胃炎的高负担状况,多个非洲国家已将轮状病毒疫苗纳入其儿童免疫规划。马拉维于2012年将G1P[8]轮状病毒疫苗(Rotarix)纳入其免疫计划。利用住院轮状病毒肠胃炎病例监测平台,我们研究了在疫苗引入之前(1998年至2012年)和之后(2013年至2014年)在马拉维传播的G1P[8]轮状病毒株的系统发育动力学。通过下一代测序获得的全基因组分析表明,所有随机选择的疫苗接种前G1P[8]株(n = 32)具有类似Wa的基因星座,而疫苗接种后G1P[8]株(n = 18)具有类似DS-1的星座。系统发育动力学分析表明,疫苗接种后G1P[8]株是通过20世纪90年代在马拉维传播的人源Wa样和DS-1样轮状病毒之间的重配事件出现的,因此被归类为非典型DS-1样重配体。G1P[8]株的最近共同祖先时间为1981年至1994年;其进化速率范围为9.7×10至4.1×10个核苷酸替换/位点/年。在1998年至2014年期间,三个不同的G1P[8]谱系按时间顺序相互取代。2005年谱系更替的可能驱动因素是基因漂变,而2013年的更替是由于重配。G1P[8]株外糖蛋白VP7内的氨基酸替换对抗原区域的结构构象没有影响,这表明它们不太可能影响疫苗诱导的中和抗体的识别。因此,马拉维出现的类似DS-1的G1P[8]轮状病毒重配体可能是由于自然基因型变异,针对此类毒株的疫苗有效性需要仔细评估。易出错的RNA依赖性RNA聚合酶和分段RNA基因组分别使轮状病毒易发生基因突变和基因组重配。这些进化机制产生新毒株,并有可能导致疫苗逃逸突变体的出现。虽然多个非洲国家已引入轮状病毒疫苗,但很少有数据描述疫苗引入前后传播的轮状病毒的进化情况。我们报告了马拉维疫苗接种后时代出现的非典型DS-1样G1P[8]毒株。从1998年到2014年,三个不同的G1P[8]谱系按时间顺序传播;突变和重配分别在2005年和2013年推动了谱系更替。外衣壳VP7糖蛋白内的氨基酸替换不影响映射抗原位点的结构构象,表明对G1特异性疫苗衍生抗体的识别影响有限。构成其余遗传骨架的基因可能在免疫逃逸中起重要作用,针对此类非典型毒株的疫苗有效性需要仔细评估。